Cartilage Regeneration in Humans with Adipose Tissue-Derived Stem Cells and Adipose Stromal Vascular Fraction Cells: Updated Status

Jaewoo Pak, Jung Hun Lee, Natalie Pak, Yoon Pak, Kwang Seung Park, Jeong Ho Jeon, Byeong Chul Jeong, Sang Hee Lee, Jaewoo Pak, Jung Hun Lee, Natalie Pak, Yoon Pak, Kwang Seung Park, Jeong Ho Jeon, Byeong Chul Jeong, Sang Hee Lee

Abstract

Adipose tissue-derived stem cells (ASCs) in the form of stromal vascular fraction (SVF) and cultured expansion have been applied in clinical settings in some countries to treat osteoarthritis (OA) of knees, one of the most common debilitating, incurable disorders. Since the first report of successful cartilage-like tissue regeneration with autologous adipose SVF containing ASCs, there has been a gradual increase in the number of publications confirming such results. Thus far, most of the reports have been limited to treatments of OA of knees. Recently, successful applications of adipose SVF in treating OA of ankles and hips have been reported. In addition, several groups have reported modified methods of applying adipose SVF, such as combining bone marrow stimulation with adipose SVF or adding additional extracellular matrix (ECM) in treating OA. Here, we present an updated, systematic review of clinical effectiveness and safety in treating OA of knees, ankles, and one hip since 2016 using ASCs in the form of adipose SVF or in cultured expansion, along with a description and suggestion of potential biological mechanisms of cartilage regeneration.

Keywords: adipose tissue-derived stem cells; human cartilage regeneration; osteoarthritis; stromal vascular fraction.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Literature selection process (PRISMA flow diagram).

References

    1. Buckwalter J.A. Articular cartilage injuries. Clin. Orthop. Relat. Res. 2002;402:21–37. doi: 10.1097/00003086-200209000-00004.
    1. Simon L.S. Osteoarthritis. Curr. Rheumatol. Rep. 1999;1:45–47. doi: 10.1007/s11926-999-0024-2.
    1. Aynardi M., Pulido L., Parvizi J., Sharkey P.F., Rothman R.H. Early mortality after modern total hip arthroplasty. Clin. Orthop. Relat. Res. 2009;467:213–218. doi: 10.1007/s11999-008-0528-5.
    1. Belmont P.J., Jr., Goodman G.P., Waterman B.R., Bader J.O., Schoenfeld A.J. Thirty-day postoperative complications and mortality following total knee arthroplasty: Incidence and risk factors among a national sample of 15,321 patients. J. Bone Jt. Surg. Am. 2014;96:20–26. doi: 10.2106/JBJS.M.00018.
    1. Glyn-Jones S., Palmer A.J., Agricola R., Price A.J., Vincent T.L., Weinans H., Carr A.J. Osteoarthritis. Lancet. 2015;386:376–387. doi: 10.1016/S0140-6736(14)60802-3.
    1. Huang G.T., Gronthos S., Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: Their biology and role in regenerative medicine. J. Dent. Res. 2009;88:792–806. doi: 10.1177/0022034509340867.
    1. Orbay H., Tobita M., Mizuno H. Mesenchymal stem cells isolated from adipose and other tissues: Basic biological properties and clinical applications. Stem Cells Int. 2012;2012:461718. doi: 10.1155/2012/461718.
    1. Via A.G., Frizziero A., Oliva F. Biological properties of mesenchymal stem cells from different sources. Muscles Ligaments Tendons J. 2012;2:154–162.
    1. Arnoczky S.P. Building a meniscus. Biologic considerations. Clin. Orthop. Relat. Res. 1999;367:S244–S253. doi: 10.1097/00003086-199910001-00024.
    1. Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 1991;9:641–650. doi: 10.1002/jor.1100090504.
    1. Szilvassy S.J. The biology of hematopoietic stem cells. Arch. Med. Res. 2003;34:446–460. doi: 10.1016/j.arcmed.2003.06.004.
    1. Carter D.R., Beaupre G.S., Giori N.J., Helms J.A. Mechanobiology of skeletal regeneration. Clin. Orthop. Relat. Res. 1998;355:S41–S55. doi: 10.1097/00003086-199810001-00006.
    1. Johnstone B., Yoo J.U. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin. Orthop. Relat. Res. 1999;367:S156–S162. doi: 10.1097/00003086-199910001-00017.
    1. Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: A case series. J. Med. Case Rep. 2011;5:296. doi: 10.1186/1752-1947-5-296.
    1. Pak J., Lee J.H., Kartolo W.A., Lee S.H. Cartilage regeneration in human with adipose tissue-derived stem cells: Current status in clinical implications. BioMed Res. Int. 2016;2016:4702674. doi: 10.1155/2016/4702674.
    1. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7:211–228. doi: 10.1089/107632701300062859.
    1. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell. 2002;13:4279–4295. doi: 10.1091/mbc.e02-02-0105.
    1. Pak J., Lee J.H., Park K.S., Jeong B.C., Lee S.H. Regeneration of cartilage in human knee osteoarthritis with autologous adipose tissue-derived stem cells and autologous extracellular matrix. Biores. Open Access. 2016;5:192–200. doi: 10.1089/biores.2016.0024.
    1. Ministry of Food and Drug Safety (MFDS) Cell Therapy: Rules and Regulations. MFDS; Seoul, Korea: 2009. [(accessed on 22 October 2015)]. Available online: .
    1. Pearle A.D., Warren R.F., Rodeo S.A. Basic science of articular cartilage and osteoarthritis. Clin. Sports Med. 2005;24:1–12. doi: 10.1016/j.csm.2004.08.007.
    1. Sophia Fox A.J., Bedi A., Rodeo S.A. The basic science of articular cartilage: Structure, composition, and function. Sports Health. 2009;1:461–468. doi: 10.1177/1941738109350438.
    1. Haslauer C.M., Elsaid K.A., Fleming B.C., Proffen B.L., Johnson V.M., Murray M.M. Loss of extracellular matrix from articular cartilage is mediated by the synovium and ligament after anterior cruciate ligament injury. Osteoarthr. Cartil. 2013;21:1950–1957. doi: 10.1016/j.joca.2013.09.003.
    1. Heard B.J., Barton K.I., Chung M., Achari Y., Shrive N.G., Frank C.B., Hart D.A. Single intra-articular dexamethasone injection immediately post-surgery in a rabbit model mitigates early inflammatory responses and post-traumatic osteoarthritis-like alterations. J. Orthop. Res. 2015;33:1826–1834. doi: 10.1002/jor.22972.
    1. Toh W.S., Brittberg M., Farr J., Foldager C.B., Gomoll A.H., Hui J.H., Richardson J.B., Roberts S., Spector M. Cellular senescence in aging and osteoarthritis. Acta Orthop. 2016;87:6–14. doi: 10.1080/17453674.2016.1235087.
    1. Ruiz-Romero C., Calamia V., Mateos J., Carreira V., Martinez-Gomariz M., Fernandez M., Blanco F.J. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: A decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol. Cell. Proteom. 2009;8:172–189. doi: 10.1074/mcp.M800292-MCP200.
    1. Wang Y., Zhao X., Lotz M., Terkeltaub R., Liu-Bryan R. Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α. Arthritis Rheum. 2015;67:2141–2153. doi: 10.1002/art.39182.
    1. Corciulo C., Lendhey M., Wilder T., Schoen H., Cornelissen A.S., Chang G., Kennedy O.D., Cronstein B.N. Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression. Nat. Commun. 2017;8:15019. doi: 10.1038/ncomms15019.
    1. Terkeltaub R., Johnson K., Murphy A., Ghosh S. Invited review: The mitochondrion in osteoarthritis. Mitochondrion. 2002;1:301–319. doi: 10.1016/S1567-7249(01)00037-X.
    1. Loeser R.F. Aging and osteoarthritis. Curr. Opin. Rheumatol. 2011;23:492–496. doi: 10.1097/BOR.0b013e3283494005.
    1. Vaamonde-Garcia C., Riveiro-Naveira R.R., Valcarcel-Ares M.N., Hermida-Carballo L., Blanco F.J., Lopez-Armada M.J. Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes. Arthritis Rheum. 2012;64:2927–2936. doi: 10.1002/art.34508.
    1. Arslan F., Lai R.C., Smeets M.B., Akeroyd L., Choo A., Aguor E.N., Timmers L., van Rijen H.V., Doevendans P.A., Pasterkamp G., et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/AKT pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 2013;10:301–312. doi: 10.1016/j.scr.2013.01.002.
    1. Zwolanek D., Satue M., Proell V., Godoy J.R., Odorfer K.I., Flicker M., Hoffmann S.C., Rulicke T., Erben R.G. Tracking mesenchymal stem cell contributions to regeneration in an immunocompetent cartilage regeneration model. JCI Insight. 2017;2:87322. doi: 10.1172/jci.insight.87322.
    1. Chute J.P. Stem cell homing. Curr. Opin. Hematol. 2006;13:399–406. doi: 10.1097/01.moh.0000245698.62511.3d.
    1. Khaldoyanidi S. Directing stem cell homing. Cell Stem Cell. 2008;2:198–200. doi: 10.1016/j.stem.2008.02.012.
    1. Sohni A., Verfaillie C.M. Mesenchymal stem cells migration homing and tracking. Stem Cells Int. 2013;2013:130763. doi: 10.1155/2013/130763.
    1. Wynn R.F., Hart C.A., Corradi-Perini C., O’Neill L., Evans C.A., Wraith J.E., Fairbairn L.J., Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood. 2004;104:2643–2645. doi: 10.1182/blood-2004-02-0526.
    1. Rüster B., Gottig S., Ludwig R.J., Bistrian R., Muller S., Seifried E., Gille J., Henschler R. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood. 2006;108:3938–3944. doi: 10.1182/blood-2006-05-025098.
    1. Docheva D., Popov C., Mutschler W., Schieker M. Human mesenchymal stem cells in contact with their environment: Surface characteristics and the integrin system. J. Cell. Mol. Med. 2007;11:21–38. doi: 10.1111/j.1582-4934.2007.00001.x.
    1. Teo G.S., Ankrum J.A., Martinelli R., Boetto S.E., Simms K., Sciuto T.E., Dvorak A.M., Karp J.M., Carman C.V. Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells. 2012;30:2472–2486. doi: 10.1002/stem.1198.
    1. Ip J.E., Wu Y., Huang J., Zhang L., Pratt R.E., Dzau V.J. Mesenchymal stem cells use integrinβ1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol. Biol. Cell. 2007;18:2873–2882. doi: 10.1091/mbc.e07-02-0166.
    1. Steingen C., Brenig F., Baumgartner L., Schmidt J., Schmidt A., Bloch W. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J. Mol. Cell. Cardiol. 2008;44:1072–1084. doi: 10.1016/j.yjmcc.2008.03.010.
    1. Mizuno K., Muneta T., Morito T., Ichinose S., Koga H., Nimura A., Mochizuki T., Sekiya I. Exogenous synovial stem cells adhere to defect of meniscus and differentiate into cartilage cells. J. Med. Dent. Sci. 2008;55:101–111.
    1. Park Y.B., Ha C.W., Kim J.A., Han W.J., Rhim J.H., Lee H.J., Kim K.J., Park Y.G., Chung J.Y. Single-stage cell-based cartilage repair in a rabbit model: Cell tracking and in vivo chondrogenesis of human umbilical cord blood-derived mesenchymal stem cells and hyaluronic acid hydrogel composite. Osteoarthr. Cartil. 2017;25:570–580. doi: 10.1016/j.joca.2016.10.012.
    1. De Windt T.S., Vonk L.A., Slaper-Cortenbach I.C.M., Nizak R., van Rijen M.H.P., Saris D.B.F. Allogeneic mscs and recycled autologous chondrons mixed in a one-stage cartilage cell transplantion: A first-in-man trial in 35 patients. Stem Cells. 2017;35:1984–1993. doi: 10.1002/stem.2657.
    1. Lai R.C., Arslan F., Lee M.M., Sze N.S., Choo A., Chen T.S., Salto-Tellez M., Timmers L., Lee C.N., El Oakley R.M., et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4:214–222. doi: 10.1016/j.scr.2009.12.003.
    1. Lai R.C., Yeo R.W., Tan K.H., Lim S.K. Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Regen. Med. 2013;8:197–209. doi: 10.2217/rme.13.4.
    1. Lai R.C., Yeo R.W., Tan S.S., Zhang B., Yin Y., Sze S.K., Choo A., Lim S.-K. Mesenchymal stem cell exosomes: The future MSC-based therapy. In: Chase L., Vemuri M., editors. Mesenchymal Stem Cell Therapy. Humana Press; New York, NY, USA: 2013. pp. 39–61.
    1. Zhang S., Chu W.C., Lai R.C., Lim S.K., Hui J.H., Toh W.S. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthr. Cartil. 2016;24:2135–2140. doi: 10.1016/j.joca.2016.06.022.
    1. Beer L., Mildner M., Ankersmit H.J. Cell secretome based drug substances in regenerative medicine: When regulatory affairs meet basic science. Ann. Transl. Med. 2017;5:170. doi: 10.21037/atm.2017.03.50.
    1. Van Niel G., D’Angelo G., Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 2018;19:213–228. doi: 10.1038/nrm.2017.125.
    1. Puetzer J.L., Petitte J.N., Loboa E.G. Comparative review of growth factors for induction of three-dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue. Tissue Eng. Part B Rev. 2010;16:435–444. doi: 10.1089/ten.teb.2009.0705.
    1. Lee M.J., Kim J., Lee K.I., Shin J.M., Chae J.I., Chung H.M. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy. 2011;13:165–178. doi: 10.3109/14653249.2010.512632.
    1. Yi T., Song S.U. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch. Pharm. Res. 2012;35:213–221. doi: 10.1007/s12272-012-0202-z.
    1. Yu D.A., Han J., Kim B.S. Stimulation of chondrogenic differentiation of mesenchymal stem cells. Int. J. Stem Cells. 2012;5:16–22. doi: 10.15283/ijsc.2012.5.1.16.
    1. Zagoura D.S., Roubelakis M.G., Bitsika V., Trohatou O., Pappa K.I., Kapelouzou A., Antsaklis A., Anagnou N.P. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut. 2012;61:894–906. doi: 10.1136/gutjnl-2011-300908.
    1. Cantinieaux D., Quertainmont R., Blacher S., Rossi L., Wanet T., Noel A., Brook G., Schoenen J., Franzen R. Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: An original strategy to avoid cell transplantation. PLoS ONE. 2013;8:e69515. doi: 10.1371/journal.pone.0069515.
    1. Shang J., Liu H., Li J., Zhou Y. Roles of hypoxia during the chondrogenic differentiation of mesenchymal stem cells. Curr. Stem Cell Res. Ther. 2014;9:141–147. doi: 10.2174/1574888X09666131230142459.
    1. Li B., Zhang H., Zeng M., He W., Li M., Huang X., Deng D.Y., Wu J. Bone marrow mesenchymal stem cells protect alveolar macrophages from lipopolysaccharide-induced apoptosis partially by inhibiting the WNT/β-catenin pathway. Cell Biol. Int. 2015;39:192–200. doi: 10.1002/cbin.10359.
    1. Bermudez M.A., Sendon-Lago J., Seoane S., Eiro N., Gonzalez F., Saa J., Vizoso F., Perez-Fernandez R. Anti-inflammatory effect of conditioned medium from human uterine cervical stem cells in uveitis. Exp. Eye Res. 2016;149:84–92. doi: 10.1016/j.exer.2016.06.022.
    1. Amann E., Wolff P., Breel E., van Griensven M., Balmayor E.R. Hyaluronic acid facilitates chondrogenesis and matrix deposition of human adipose derived mesenchymal stem cells and human chondrocytes co-cultures. Acta Biomater. 2017;52:130–144. doi: 10.1016/j.actbio.2017.01.064.
    1. Van der Pol E., Boing A.N., Harrison P., Sturk A., Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 2012;64:676–705. doi: 10.1124/pr.112.005983.
    1. Rani S., Ryan A.E., Griffin M.D., Ritter T. Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications. Mol. Ther. 2015;23:812–823. doi: 10.1038/mt.2015.44.
    1. Deregibus M.C., Cantaluppi V., Calogero R., Lo Iacono M., Tetta C., Biancone L., Bruno S., Bussolati B., Camussi G. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mrna. Blood. 2007;110:2440–2448. doi: 10.1182/blood-2007-03-078709.
    1. Zhang B., Wu X., Zhang X., Sun Y., Yan Y., Shi H., Zhu Y., Wu L., Pan Z., Zhu W., et al. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the WNT4/β-catenin pathway. Stem Cells Transl. Med. 2015;4:513–522. doi: 10.5966/sctm.2014-0267.
    1. Zhang J., Guan J., Niu X., Hu G., Guo S., Li Q., Xie Z., Zhang C., Wang Y. Exosomes released from human induced pluripotent stem cells-derived mscs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J. Transl. Med. 2015;13:49. doi: 10.1186/s12967-015-0417-0.
    1. Anderson J.D., Johansson H.J., Graham C.S., Vesterlund M., Pham M.T., Bramlett C.S., Montgomery E.N., Mellema M.S., Bardini R.L., Contreras Z., et al. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappab signaling. Stem Cells. 2016;34:601–613. doi: 10.1002/stem.2298.
    1. Li X., Chen C., Wei L., Li Q., Niu X., Xu Y., Wang Y., Zhao J. Exosomes derived from endothelial progenitor cells attenuate vascular repair and accelerate reendothelialization by enhancing endothelial function. Cytotherapy. 2016;18:253–262. doi: 10.1016/j.jcyt.2015.11.009.
    1. Basu J., Ludlow J.W. Exosomes for repair, regeneration and rejuvenation. Expert Opin. Biol. Ther. 2016;16:489–506. doi: 10.1517/14712598.2016.1131976.
    1. Raposo G., Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell Biol. 2013;200:373–383. doi: 10.1083/jcb.201211138.
    1. Edgar J.R. Q&A: What are exosomes, exactly? BMC Biol. 2016;14:46.
    1. Feng D., Zhao W.L., Ye Y.Y., Bai X.C., Liu R.Q., Chang L.F., Zhou Q., Sui S.F. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 2010;11:675–687. doi: 10.1111/j.1600-0854.2010.01041.x.
    1. Lai R.C., Tan S.S., Teh B.J., Sze S.K., Arslan F., de Kleijn D.P., Choo A., Lim S.K. Proteolytic potential of the MSC exosome proteome: Implications for an exosome-mediated delivery of therapeutic proteasome. Int. J. Proteom. 2012;2012:971907. doi: 10.1155/2012/971907.
    1. Svensson K.J., Christianson H.C., Wittrup A., Bourseau-Guilmain E., Lindqvist E., Svensson L.M., Morgelin M., Belting M. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid raft-mediated endocytosis negatively regulated by caveolin-1. J. Biol. Chem. 2013;288:17713–17724. doi: 10.1074/jbc.M112.445403.
    1. Luthje J. Origin, metabolism and function of extracellular adenine nucleotides in the blood. Klin. Wochenschr. 1989;67:317–327. doi: 10.1007/BF01741386.
    1. Aymeric L., Apetoh L., Ghiringhelli F., Tesniere A., Martins I., Kroemer G., Smyth M.J., Zitvogel L. Tumor cell death and atp release prime dendritic cells and efficient anticancer immunity. Cancer Res. 2010;70:855–858. doi: 10.1158/0008-5472.CAN-09-3566.
    1. Vitiello L., Gorini S., Rosano G., la Sala A. Immunoregulation through extracellular nucleotides. Blood. 2012;120:511–518. doi: 10.1182/blood-2012-01-406496.
    1. Jacobson K.A., Gao Z.G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 2006;5:247–264. doi: 10.1038/nrd1983.
    1. Chekeni F.B., Elliott M.R., Sandilos J.K., Walk S.F., Kinchen J.M., Lazarowski E.R., Armstrong A.J., Penuela S., Laird D.W., Salvesen G.S., et al. Pannexin 1 channels mediate "find-me" signal release and membrane permeability during apoptosis. Nature. 2010;467:863–867. doi: 10.1038/nature09413.
    1. Colgan S.P., Eltzschig H.K., Eckle T., Thompson L.F. Physiological roles for ecto-5′-nucleotidase (CD73) Purinergic Signal. 2006;2:351–360. doi: 10.1007/s11302-005-5302-5.
    1. Beier F., Loeser R.F. Biology and pathology of Rho GTPase, PI-3 kinase-AKT, and MAP kinase signaling pathways in chondrocytes. J. Cell. Biochem. 2010;110:573–580. doi: 10.1002/jcb.22604.
    1. Song G., Ouyang G., Bao S. The activation of AKT/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 2005;9:59–71. doi: 10.1111/j.1582-4934.2005.tb00337.x.
    1. Chambard J.C., Lefloch R., Pouyssegur J., Lenormand P. ERK implication in cell cycle regulation. Biochim. Biophys. Acta. 2007;1773:1299–1310. doi: 10.1016/j.bbamcr.2006.11.010.
    1. Fahy N., de Vries-van Melle M.L., Lehmann J., Wei W., Grotenhuis N., Farrell E., van der Kraan P.M., Murphy J.M., Bastiaansen-Jenniskens Y.M., van Osch G.J. Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state. Osteoarthr. Cartil. 2014;22:1167–1175. doi: 10.1016/j.joca.2014.05.021.
    1. Ding J., Chen B., Lv T., Liu X., Fu X., Wang Q., Yan L., Kang N., Cao Y., Xiao R. Bone marrow mesenchymal stem cell-based engineered cartilage ameliorates polyglycolic acid/polylactic acid scaffold-induced inflammation through M2 polarization of macrophages in a pig model. Stem Cells Transl. Med. 2016;5:1079–1089. doi: 10.5966/sctm.2015-0263.
    1. Zhang S., Chu W., Lai R., Hui J., Lee E., Lim S., Toh W. Human mesenchymal stem cell-derived exosomes promote orderly cartilage regeneration in an immunocompetent rat osteochondral defect model. Cytotherapy. 2016;18:S13. doi: 10.1016/j.jcyt.2016.03.035.
    1. Zhang B., Yin Y., Lai R.C., Tan S.S., Choo A.B., Lim S.K. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2014;23:1233–1244. doi: 10.1089/scd.2013.0479.
    1. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb. Haemost. 2004;91:4–15. doi: 10.1160/TH03-07-0440.
    1. Centeno C.J., Busse D., Kisiday J., Keohan C., Freeman M., Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11:343–353.
    1. Eppley B.L., Pietrzak W.S., Blanton M. Platelet-rich plasma: A review of biology and applications in plastic surgery. Plast Reconstr. Surg. 2006;118:147e–159e. doi: 10.1097/.
    1. Fufa D., Shealy B., Jacobson M., Kevy S., Murray M.M. Activation of platelet-rich plasma using soluble type i collagen. J. Oral Maxillofac. Surg. 2008;66:684–690. doi: 10.1016/j.joms.2007.06.635.
    1. Pak J., Chang J.J., Lee J.H., Lee S.H. Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. BMC Musculoskelet. Disord. 2013;14:337. doi: 10.1186/1471-2474-14-337.
    1. Uzuki M., Sawai T. A comparison of the affinity of sodium hyaluronate of various molecular weights for degenerated cartilage: A histochemical study using hyaluronic acid binding protein. Int. Congr. Ser. 2001;1223:279–284. doi: 10.1016/S0531-5131(01)00429-0.
    1. Benders K.E., van Weeren P.R., Badylak S.F., Saris D.B., Dhert W.J., Malda J. Extracellular matrix scaffolds for cartilage and bone regeneration. Trends Biotechnol. 2013;31:169–176. doi: 10.1016/j.tibtech.2012.12.004.
    1. Kim Y.S., Lee M., Koh Y.G. Additional mesenchymal stem cell injection improves the outcomes of marrow stimulation combined with supramalleolar osteotomy in varus ankle osteoarthritis: Short-term clinical results with second-look arthroscopic evaluation. J. Exp. Orthop. 2016;3:12. doi: 10.1186/s40634-016-0048-2.
    1. Fodor P.B., Paulseth S.G. Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint. Aesthet. Surg. J. 2016;36:229–236. doi: 10.1093/asj/sjv135.
    1. Baer P.C., Geiger H. Adipose-derived mesenchymal stromal/stem cells: Tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012;2012:812693. doi: 10.1155/2012/812693.
    1. Jo C.H., Lee Y.G., Shin W.H., Kim H., Chai J.W., Jeong E.C., Kim J.E., Shim H., Shin J.S., Shin I.S., et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: A proof-of-concept clinical trial. Stem Cells. 2014;32:1254–1266. doi: 10.1002/stem.1634.
    1. Pers Y.M., Rackwitz L., Ferreira R., Pullig O., Delfour C., Barry F., Sensebe L., Casteilla L., Fleury S., Bourin P., et al. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: A phase i dose-escalation trial. Stem Cells Transl. Med. 2016;5:847–856. doi: 10.5966/sctm.2015-0245.
    1. Nguyen P.D., Tran T.D., Nguyen H.T., Vu H.T., Le P.T., Phan N.L., Vu N.B., Phan N.K., van Pham P. Comparative clinical observation of arthroscopic microfracture in the presence and absence of a stromal vascular fraction injection for osteoarthritis. Stem Cells Transl. Med. 2017;6:187–195. doi: 10.5966/sctm.2016-0023.
    1. Pak J., Lee J.H., Park K.S., Lee S.H. Efficacy of autologous adipose tissue-derived stem cells with extracellular matrix and hyaluronic acid on human hip osteoarthritis. Biomed. Res. 2017;28:1654–1658.
    1. Song Y., Du H., Dai C., Zhang L., Li S., Hunter D.J., Lu L., Bao C. Human adipose-derived mesenchymal stem cells for osteoarthritis: A pilot study with long-term follow-up and repeated injections. Regen. Med. 2018;13:295–307. doi: 10.2217/rme-2017-0152.
    1. Kim Y.S., Koh Y.G. Injection of mesenchymal stem cells as a supplementary strategy of marrow stimulation improves cartilage regeneration after lateral sliding calcaneal osteotomy for varus ankle osteoarthritis: Clinical and second-look arthroscopic results. Arthroscopy. 2016;32:878–889. doi: 10.1016/j.arthro.2016.01.020.
    1. Jo C.H., Chai J.W., Jeong E.C., Oh S., Shin J.S., Shim H., Yoon K.S. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: A 2-year follow-up study. Am. J. Sports Med. 2017;45:2774–2783. doi: 10.1177/0363546517716641.
    1. Kuah D., Sivell S., Longworth T., James K., Guermazi A., Cicuttini F., Wang Y., Craig S., Comin G., Robinson D., et al. Safety, tolerability and efficacy of intra-articular progenza in knee osteoarthritis: A randomized double-blind placebo-controlled single ascending dose study. J. Transl. Med. 2018;16:49. doi: 10.1186/s12967-018-1420-z.
    1. Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The prisma statement. Ann. Intern. Med. 2009;151:264–269. doi: 10.7326/0003-4819-151-4-200908180-00135.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren